Search clinical trials for: melanoma,adjuvant therapy,kit mutated melanoma
Total 4026 results
-
Peking University Cancer Hospital & InstituteUnknown
-
University Hospital, MontpellierRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
SOLTI Breast Cancer Research GroupNovartisRecruitingMelanoma | Sarcoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Uterine Carcinosarcoma | Mesothelioma | Cholangiocarcinoma | Lung Adenocarcinoma | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal... and other conditionsSpain
-
Southwest Oncology GroupNational Cancer Institute (NCI)RecruitingLung Adenocarcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Squamous Non-Small Cell CarcinomaUnited States, Guam
-
Hospices Civils de LyonRecruiting
-
Yonsei UniversityRecruiting
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); ChiRhoClin...RecruitingLynch Syndrome | Pancreas Cancer | Gene Mutation | Peutz-Jeghers Syndrome (PJS) | Germline Mutation CarrierUnited States
-
Novartis PharmaceuticalsActive, not recruitingMelanomaItaly, Czechia, Germany, Hungary, Canada, United States, Argentina, Australia, Austria, France, Israel, Russian Federation, Spain, Sweden, United Kingdom, Thailand, Belgium, Brazil, Greece, Switzerland, Mexico, Netherlands, Denmark, C... and more
-
Daiichi Sankyo Co., Ltd.Daiichi SankyoActive, not recruitingMelanomaKorea, Republic of, China
-
OnKure, Inc.Active, not recruitingMelanoma | NRAS Gene Mutation | RAS MutationUnited States
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; Weill Medical College of Cornell UniversityActive, not recruiting
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia (ALL) | Chronic Myelogenous Leukemia (CML) | Metastatic Gastrointestinal Stromal Tumors (GIST) | Receptor Tyrosine Kinase (KIT) Mutated MelanomaItaly, United Kingdom, Canada, Singapore, Netherlands, France, Korea, Republic of, United States, Slovakia, Hungary, Russian Federation, Hong Kong, Spain, Israel, Sweden, Austria
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.; ExelixisActive, not recruitingMelanoma | Skin CancerUnited States
-
Tempus AIGlaxoSmithKlineActive, not recruitingMelanoma | Head and Neck Cancer | Pancreatic Cancer | Esophageal Cancer | Solid Tumor | Metastatic Cancer | Endometrial Cancer | Urologic Cancer | Breast Tumor | Locally Advanced Solid Tumor | Lung Tumor | Colon Tumor, MalignantUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Metastatic Malignant Neoplasm in the Brain | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Sumitomo Pharma America, Inc.CompletedAdvanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated MelanomaUnited States
-
Fondazione Melanoma OnlusWithdrawn
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
Institut de Cancérologie de LorraineCompleted
-
Haihe Biopharma Co., Ltd.TerminatedMelanoma | Erdheim-Chester Disease | Non-Small-Cell Lung Cancer | Advanced Tumors | Other RAS/RAF/MEK/ERK Mutated TumorsUnited States, China
-
Novartis PharmaceuticalsCompletedBRAF v600 Mutated Metastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteExelixisCompleted
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
West Cancer CenterAmgen; University of Tennessee Health Science CenterUnknownMelanoma | BRAF Gene MutationUnited States
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Tocagen Inc.TerminatedMelanoma | Sarcoma | Lymphoma | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | IDH1 Mutated Solid Tumors | IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)United States
-
Center Eugene MarquisCompletedMalignant MelanomaFrance
-
National Cancer Institute (NCI)TerminatedMelanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Gastrointestinal CancerUnited States
-
CelgeneTerminatedNeoplasm MetastasisUnited States, Australia
-
Duke UniversityWithdrawn
-
The Netherlands Cancer InstituteUnknownMelanoma | Skin NeoplasmsNetherlands
-
Mohammed M MilhemGenentech, Inc.TerminatedMelanoma | Metastatic Melanoma | BRAF-mutated Metastatic Melanoma | V600EBRAF-mutated Metastatic MelanomaUnited States
-
Bristol-Myers SquibbCompleted
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
California Pacific Medical Center Research InstitutePfizerWithdrawnMelanomaUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownMelanoma BRAF V600E/K Mutated | CDNKN2A Loss DefinedFrance
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Germany, Singapore, Italy, Australia, Netherlands, Sweden, Spain, Canada, Switzerland, Argentina, Brazil, China
-
Dermatologic Cooperative Oncology GroupUnknownTherapy | Adjuvant | Stage III Malignant Melanoma | Interferon AlphaGermany
-
Wright State UniversityRecruitingAging | Actinic Keratoses | Non-Melanoma Skin CancerUnited States
-
Georgiamune IncNot yet recruitingSolid Tumor | Melanoma Stage IV
-
Peking University Cancer Hospital & InstituteNot yet recruitingMelanoma | Metastatic Melanoma | Mucosal MelanomaChina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Not yet recruitingMelanoma | Non-Hodgkin Lymphoma | Breast Carcinoma | Lung Non-Small Cell Carcinoma | Colorectal Carcinoma
-
Melanoma and Skin Cancer Trials LimitedNot yet recruitingLocally Advanced Cutaneous Squamous Cell Carcinoma
-
National Cancer Centre, SingaporeRecruitingAdvanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung CancerKorea, Republic of, Taiwan, Singapore
-
Thomas Jefferson UniversityNot yet recruitingLocally Advanced Unresectable Uveal MelanomaUnited States
-
Royal Marsden NHS Foundation TrustNot yet recruiting
-
AstraZenecaDaiichi SankyoNot yet recruiting